Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001736243-25-000003
Filing Date
2025-05-20
Accepted
2025-05-20 15:32:14
Documents
1
Effectiveness Date
2025-05-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10514
  Complete submission text file 0001736243-25-000003.txt   11758
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-546703 | Film No.: 25968313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)